Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esther Need

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|October 24, 2024
Tumor agnostic ultrasmall nanoprobes for fluorescence-guided surgical resection in peritoneal metastasisNeetu Singh, Wenxi Xia, Esther Need, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
Image-Guided Targeting of Mitochondrial Metabolism Sensitizes Pediatric Malignant Rhabdoid Tumors to Low Dose RadiotherapyWenxi Xia, Matthew Goff, Carmine Schiavone, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
FOLR1-targeted Actinium-225-based Alpha-particle Therapy Eliminates Ovarian CancerNeetu Singh, Esther Need, Ayden Berndt, et al.
Science Advances|June 24, 2026
FOLR1-targeted actinium-225-based alpha-particle therapy eliminates ovarian cancerNeetu Singh, Esther Need, Ayden Berndt, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
European Journal of Nuclear Medicine and Molecular Imaging|October 24, 2024
Tumor agnostic ultrasmall nanoprobes for fluorescence-guided surgical resection in peritoneal metastasisNeetu Singh, Wenxi Xia, Esther Need, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
Image-Guided Targeting of Mitochondrial Metabolism Sensitizes Pediatric Malignant Rhabdoid Tumors to Low Dose RadiotherapyWenxi Xia, Matthew Goff, Carmine Schiavone, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
FOLR1-targeted Actinium-225-based Alpha-particle Therapy Eliminates Ovarian CancerNeetu Singh, Esther Need, Ayden Berndt, et al.
Science Advances|June 24, 2026
FOLR1-targeted actinium-225-based alpha-particle therapy eliminates ovarian cancerNeetu Singh, Esther Need, Ayden Berndt, et al.
Pageof 1